Also trades as: 0L35.L (LSE) · $vol 0M
SRPT NASDAQ
Sarepta Therapeutics, Inc.
1W: -6.3%
1M: -24.6%
3M: -8.8%
YTD: -17.9%
1Y: -9.4%
3Y: -85.8%
5Y: -80.7%
$17.50
-0.07 (-0.40%)
Weekly Expected Move ±8.4%
$15
$16
$18
$19
$20
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$2B
Revenue
-20.4% YoY
$-137M
Net Income
-135.9% YoY
$-131M
Free Cash Flow
+70.9% YoY
62.8%
Gross Margin
3.3%
Op. Margin
-1.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-9.5%
ROA-4.0%
ROIC-6.3%
Valuation
P/E-12.2
P/B1.2
EV/EBITDA-147.6
Leverage
Debt/Equity0.68
Current Ratio4.42
Interest Cov.-1.0x
Quality Scores
Piotroski F4/9
Altman Z-0.11
Beneish M-2.57